Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+38.7%
5Y CAGR+61.9%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+38.7%/yr
Annual compound
5Y CAGR
+61.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
11.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$191.41M+20.5%
2024$158.83M+38.9%
2023$114.36M+59.6%
2022$71.66M+65.8%
2021$43.22M+151.4%
2020$17.19M+73.2%
2019$9.92M-